Acknowledgment and Consent for Disclosure of Section 712(c)(2)(B) of the Federal Food, Drug, and Cosmetic Act and 18 U.S.C. §208 Particular Matter Waiver Name: - Vernakalant - Document - PDFSEARCH.IO

First Page	Meta Content
	Acknowledgment and Consent for Disclosure of Section 712(c)(2)(B) of the Federal Food, Drug, and Cosmetic Act and 18 U.S.C. §208 Particular Matter Waiver Name: Add to Reading List Document Date: 2007-11-26 09:47:46 Open Document File Size: 34,73 KB Share Result on Facebook Company Solvay S.A. / Solvay Pharmaceuticals Inc. / Astellas Pharma Inc. / Cardiome Pharma Corp / / Currency USD / / Event FDA Phase / / MedicalCondition atrial fibrillation / atrial flutter / / Organization FDA / Steering Committee on an Unrelated Issue Competitor Less / Renal Drugs Advisory Committee / / Person Barry Massie / / Product Vernakalant Hydrochloride Injection / IV solution / / SocialTag Medicine Organic chemistry Alcohols Pyrrolidines Vernakalant Potassium channel blockers Atrial flutter Atrial fibrillation Fibrillation Cardiac dysrhythmia

Acknowledgment and Consent for Disclosure of Section 712(c)(2)(B) of the Federal Food, Drug, and Cosmetic Act and 18 U.S.C. §208 Particular Matter Waiver Name:Add to Reading List